SILCOPHL logo

Silco Pharmaceuticals Limited Stock Price

DSE:SILCOPHL Community·৳1.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

SILCOPHL Share Price Performance

৳13.80
-2.10 (-13.21%)
৳13.80
-2.10 (-13.21%)
Price ৳13.80

SILCOPHL Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet with proven track record.

3 Risks
1 Reward

Silco Pharmaceuticals Limited Key Details

৳428.6m

Revenue

৳295.2m

Cost of Revenue

৳133.4m

Gross Profit

৳86.9m

Other Expenses

৳46.6m

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
0.45
31.13%
10.86%
0%
View Full Analysis

About SILCOPHL

Founded
1995
Employees
313
CEO
Md. Haque Rukan
WebsiteView website
www.silcopharma.com

Silco Pharmaceuticals Limited engages in manufacturing and marketing of finished pharmaceutical products in Bangladesh and internationally. It offers products in the therapeutic areas of analgesic and antipyretic, anti-platelet, antiasthmatic, antibiotic, antidepressant, antidiabetic, antiemetic, antifungal, antihistamin, antihypertensive and antianginal, antimicrobial, antiprotozoal, antispasmodic, antiulcerant, anxiolytic, calcium and combinations, central muscle relaxants, diuretics, gastroprokinetic, haematinic, vitamins and minerals, laxatives, lipid lowering agents, mycolytic expectorants, and NSAIDs, as well as anti-inflammatory, narcotics, and multi-medicines. The company also exports its medicines to Afghanistan, Bhutan, Myanmar, Ivory Coast, Kenya, Mauritius, Somalia, Tanzania, Uganda. Silco Pharmaceuticals Limited was incorporated in 1995 and is headquartered in Sylhet, Bangladesh.

Recent SILCOPHL News & Updates

Recent updates

No updates